Biography
Dr Charlotte Pawlyn is a Haematologist and
CRUK Clinician Scientist with an interest in the bone marrow malignancy multiple myeloma. In 2020 she became Group Leader of the Myeloma Biology and Therapeutics Group in the
Division of Cancer Therapeutics.
In 2016, Dr Pawlyn completed a Wellcome Trust funded PhD Fellowship at The Institute of Cancer Research, undertaking laboratory research to identify novel epigenetic targets for myeloma therapy. During her PhD was awarded a ‘Women in Cancer Research Scholar Award’ from the
American Association of Cancer Research.
Dr Pawlyn was awarded a CRUK Clinician Scientist Fellowship in 2020 to fund her laboratory research which focusses on identifying therapeutic targets to improve outcomes for patients with immunomodulatory drug resistant and high-risk myeloma.
In addition to her laboratory studies Dr Pawlyn is actively involved in running several clinical trials as a member of the UK NCRI group, the UK Myeloma Research Alliance (UKMRA), including the large national frontline studies, Myeloma XI and Myeloma XIV. She is a member of the Research Advisory Group for the
Myeloma UK charity.